Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

4,300 companies

Ticker	Company	Revenue	Net income	Net margin ▴	Return on equity	Revenue growth	Diluted EPS
NNNN	Anbio Biotechnology Manufacturing · Year ended 2025-12-31 · USD	$8.65M	$6.40M	74.1%	21.2%	5.6%	$0.15
ZVRA	Zevra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$106.47M	$83.23M	78.2%	53.8%	350.9%	$1.35
CFOR	CapForce Inc. Services · Year ended 2025-12-31 · USD	$30.20M	$23.62M	78.2%	74.1%	481.2%	$2.32
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
SPG	Simon Property Group Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$6.36B	$5.36B	84.3%	82.9%	6.7%	$14.17
TRNO	Terreno Realty Corp Finance & Real Estate · Year ended 2025-12-31 · USD	$476.38M	$402.99M	84.6%	9.7%	24.5%	$3.91
RYN	Rayonier Inc Finance & Real Estate · Year ended 2025-12-31 · USD	$484.49M	$474.38M	97.9%	21.5%	-51.0%	$3.03
JOYY	JOYY Inc. Services · Year ended 2025-12-31 · USD	$2.12B	$2.10B	98.8%	32.1%	-5.1%	$1.97
AARD	Aardvark Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$57.59M	n/a	-54.0%	n/a	-$2.93
AASP	Agassi Sports Entertainment Corp. Retail Trade · Year ended 2025-12-31 · USD	n/a	-$9.49M	n/a	n/m	n/a	n/a
ABCB	Ameris Bancorp Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$412.15M	n/a	10.1%	n/a	$6.00
ABEO	Abeona Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$71.18M	n/a	44.7%	n/a	$1.01
ABOS	Acumen Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$121.33M	n/a	-172.3%	n/a	-$2.00
ABR	Arbor Realty Trust Inc Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$157.83M	n/a	5.1%	n/a	$0.56
ABSI	Absci Corp Services · Year ended 2025-12-31 · USD	$2.80M	-$115.18M	n/m	-60.8%	-38.2%	-$0.84
ABVC	Abvc Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$296.0K	-$7.91M	n/m	-71.2%	-41.9%	-$0.39
ACET	Adicet Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$116.80M	n/a	-73.4%	n/a	-$16.95
ACHR	Archer Aviation Inc. Manufacturing · Year ended 2025-12-31 · USD	$300.0K	-$618.20M	n/m	-28.1%	n/a	-$0.99
ACHV	Achieve Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$54.65M	n/a	-254.0%	n/a	-$1.25
ACON	Aclarion, Inc. Services · Year ended 2025-12-31 · USD	$75.7K	-$7.23M	n/m	-56.4%	65.6%	-$13.61
ACRV	Acrivon Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.91M	n/a	-69.2%	n/a	-$2.02
ACTU	Actuate Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.23M	n/a	-280.5%	n/a	-$1.06
ACXP	Acurx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.97M	n/a	-151.2%	n/a	-$5.32
ADAM	Adamas Trust, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$137.66M	n/a	9.6%	n/a	$1.10
ADGM	Adagio Medical Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$25.08M	n/a	-202.3%	n/a	-$1.51

Rows per page: 2550 100